Worldwide Healthcare Trust PLC GBPLSE: WWH

Worldwide Healthcare Trust PLC GBP: Transaction in Own Shares

· Issued by Worldwide Healthcare Trust PLC GBP via PR Newswire

Summary by 6ix AI

Worldwide Healthcare Trust PLC bought 1,137,845 of its Ordinary shares of 2.5p each on the market on October 7, 2026 at 369.15 pence per share. The shares will be held in treasury, meaning the company keeps them rather than cancelling them.

Key details

  • After the purchase, the company holds 260,720,703 Ordinary shares in treasury and has 601,665,200 Ordinary shares in issue.
  • Total voting rights in the company after the repurchase are 340,944,497. Shareholders may use this figure to work out whether they must report their holding, or a change to it, under the Financial Conduct Authority's (FCA) Disclosure Guidance and Transparency Rules.
  • The buyback was made under authority granted at the company's Annual General Meeting on July 14, 2026, which allows market purchases of up to an aggregate maximum of 53,782,409 shares.

6ix AI wrote this summary from the release below and checked it against the release.

For immediate release

7 October 2026

WORLDWIDE HEALTHCARE TRUST PLC

(the "Company")

MARKET PURCHASE OF COMPANY'S OWN SHARES

This notification is given, pursuant to the authority granted at an Annual General Meeting of the Company held on 14 July 2026 to make market purchases of the Company's own shares up to an aggregate maximum of 53,782,409.

The Company has purchased a market total of 1,137,845 Ordinary shares of 2.5p each in the capital of the Company today at a price of 369.15 pence per share. These shares will be held in treasury.

Following this transaction, the Company hereby notifies the market that the resultant number of Ordinary shares held by the Company in treasury is 260,720,703 and the total number of Ordinary shares that the Company has in issue is 601,665,200 so that the total number of voting rights in the Company following the repurchase is 340,944,497.

The figure of 340,944,497 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

For and on behalf of

Frostrow Capital LLP

Company Secretary

For further information, please contact:

Mark Pope

Frostrow Capital LLP

Tel: 020 3 0084913




Worldwide Healthcare Trust PLC GBP on 6ix

Earlier from Worldwide Healthcare Trust PLC GBP

Later from Worldwide Healthcare Trust PLC GBP

All Worldwide Healthcare Trust PLC GBP news releases